CD44 and glioblastoma: Taken together, these data support a model in which Nf1 loss in M-GBM cells leads to hyperactivation of the AKT/mTOR pathway, which positively regulates Ccl5 expression and increases M-GBM cell survival through CD44 signaling (Figure 6G).